<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260616069840N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-19</date_registration>
      <primary_sponsor>Kashan University of Medical Sciences</primary_sponsor>
      <public_title>The Effectiveness of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) on Emotional Security, Loneliness, Alexithymia, and Well-Being in Adolescents with Divorced Parents Living in Kashan</public_title>
      <acronym></acronym>
      <scientific_title>The Effectiveness of Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) on Emotional Security, Loneliness, Alexithymia, and Well-Being in Adolescents with Divorced Parents Living in Kashan</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-07-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/90964</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>children of divorce.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Adolescents aged 12 to 18 years who are children of divorce.In this group, Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) will be delivered in 12 sessions of 45 to 60 minutes for the adolescents. Additionally, several sessions will be conducted for their guardians or parents. Intervention 2: Control group: Adolescents aged 12 to 18 years who are children of divorce will not receive any treatment and will remain on a waitlist.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual participant data from this study will be shared after the trial's completion in a de-identified manner, without any identifiable information. Access to raw data related to the primary outcome variables, including loneliness scores, alexithymia, emotional security, and psychological well-being, will be made available upon request to qualified researchers. Under no circumstances will participants' identifiable information be accessible to individuals outside the research team at any stage.

When:
The access period begins 6 months and 2 yeras after the results are published

To whom:
De-identified individual participant data will be made available to qualified researchers. Requests will be accepted only from investigators affiliated with recognized academic institutions, research centers, or scientific organizations with a clear and relevant research purpose. Requests will be reviewed and approved by the study investigators.

Conditions:
De-identified individual participant data will be used solely for scientific and non-commercial research purposes. Data use is limited to statistical analyses consistent with or complementary to the objectives of the original study. Commercial use, marketing purposes, or any non-scientific applications are strictly prohibited. Data recipients must maintain confidentiality, avoid any attempt to re-identify participants, and are not permitted to share the data with third parties without written permission from the study investigators. Access will be granted only after approval by the principal investigators and in accordance with ethical research principles.

Where to obtain:
Qualified applicants seeking access to the de-identified data from this study may submit their requests to the principal investigator, Reyhaneh Sadat Sherafat, or to the supervising professor, Dr. Zahra Zanjanizadeh (Zanjani). Requests will be reviewed on a priority basis via email. If necessary, further correspondence will be conducted through the university where the study was conducted.
· Reyhaneh Sadat Sherafat (Principal Investigator): reyhanesadatsherafat1381@gmail.com

How to obtain:
Upon receipt of a request for access to de-identified individual participant data, the request will be reviewed by the principal investigator and the research team. The first step involves assessing the scientific merit and eligibility of the applicant. If preliminarily approved, the requester will be required to sign a data use agreement, including confidentiality and non-reidentification commitments. After completion of the required documentation, the requested data will be prepared and shared electronically with the applicant. Additional clarifications, if needed, will be handled via email correspondence. The entire process typically takes between 2 to 4 weeks.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Reyhaneh Sadat Sherafat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 11, 5th Unit, East Banafsheh Alley, South Salimi Jahromi Street, East Ferdous Boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1481746851</zip>
        <telephone>+98 21 4409 3573</telephone>
        <email>Sherafat-r@kaums.ac.ir</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reyhaneh Sadat Sherafat</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 11, 5th Unit, East Banafsheh Alley, South Salimi Jahromi Street, East Ferdous Boulevard</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1481746851</zip>
        <telephone>+98 21 4409 3573</telephone>
        <email>reyhanesadatsherafat1381@gmail.com</email>
        <affiliation>Kashan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Adolescents between 12 and 18 years of age
At least 6 months and at most 5 years have passed since the parents' divorce
A score below 27 on the Emotional Security Scale (from the Emotional Security Questionnaire)
Reporting parental divorce as a traumatic event during the initial interview
Absence of severe psychiatric disorders requiring medication or hospitalization (e.g., severe psychotic disorders)
Informed consent from both the adolescent and their legal guardian, along with a willingness to participate in the study
Basic literacy skills to complete questionnaires or participate in exercises
Basic literacy skills to complete questionnaires or participate in exercises
Not receiving concurrent psychological intervention</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Development of an acute psychiatric condition that prevents continuation of treatment
Occurrence of suicidal ideation reported by the participant
Occurrence of an incident that prevents or disrupts attendance at sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Adolescents aged 12 to 18 years who are children of divorce.In this group, Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) will be delivered in 12 sessions of 45 to 60 minutes for the adolescents. Additionally, several sessions will be conducted for their guardians or parents.</i_keyword>
      <i_keyword>Control group: Adolescents aged 12 to 18 years who are children of divorce will not receive any treatment and will remain on a waitlist</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Emotional Security. Timepoint: Emotional security will be measured at the beginning of the study (before the intervention) and at the end of the study, after receiving 12 sessions of treatment. Method of measurement: Security in the Family System (SIFS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Loneliness. Timepoint: Loneliness will be measured at the beginning of the study (before the intervention) and at the end of the study, after receiving 12 sessions of treatment. Method of measurement: UCLA Loneliness Scale.</sec_outcome>
      <sec_outcome>Alexithymia. Timepoint: Alexithymia will be measured at the beginning of the study (before the intervention) and at the end of the study, after receiving 12 sessions of treatment. Method of measurement: Toronto Alexithymia Scale (TAS-20).</sec_outcome>
      <sec_outcome>Well being. Timepoint: Psychological well-being will be measured at the beginning of the study (before the intervention) and at the end of the study, after receiving 12 sessions of treatment. Method of measurement: Multidimensional Well being in Youth Scale (MWYS).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kashan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-24</approval_date>
        <contact_name>Ethics committee of Kashan University of Medical Sciences</contact_name>
        <contact_address>Kashan - Qotb-e Ravandi Boulevard - Pezeshk Boulevard (University Campus) kashan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
